Efficacy and safety of single-dose mizoribine for patients with rheumatoid arthritis: results at 6 months after switching from a multiple-dose regimen without a change in total daily dose.

Source:http://linkedlifedata.com/resource/pubmed/id/21107634

Download in:

View as

General Info

PMID
21107634